Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma

Published:2019-04 Issue: Volume:447 Page:1-11
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Jiang Zhiyuan,Zhou Qingqing,Ge Chao,Yang Jing,Li Hong,Chen Taoyang,Xie Haiyang,Cui Ying,Shao Miaomiao,Li Jinjun,Tian Hua

Funder

National Natural Science Foundation of China

Research Project of Shanghai Municipal Health and Family Planning Commission

SKLORG Research Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma;Maluccio;Ca - Cancer J. Clin.,2012

2. Cancer statistics, 2018;Siegel;Ca - Cancer J. Clin.,2018

3. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma;Wang;Hepatology,2013

4. Targeting the ubiquitin-proteasome system for cancer therapy;Shen;Expert Opin. Ther. Targets,2013

5. The ubiquitin-proteasome system and its potential application in hepatocellular carcinoma therapy;Chen;Cancer Lett.,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of Metastasis and Growth of Colorectal Cancer via Targeting the PTEN Pathway: An Update on the Progress of LncRNA MLLT4-AS1;Recent Patents on Anti-Cancer Drug Discovery;2024-06-03

2. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling;Journal of Experimental & Clinical Cancer Research;2024-05-14

3. LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation;Cellular Oncology;2024-04-24

4. PSMD4 drives progression of hepatocellular carcinoma via Akt/COX2 pathway and p53 inhibition;Human Cell;2023-06-19

5. PSMD4 drives progression of hepatocellular carcinoma via Akt/COX2 pathway and p53 inhibition;2023-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3